Everpar Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $353K | Buy |
792
+44
| +6% | +$19.6K | 0.16% | 172 |
|
|
2025
Q1 | $363K | Buy |
748
+81
| +12% | +$39.3K | 0.19% | 148 |
|
|
2024
Q4 | $269K | Sell |
667
-26
| -4% | -$10.5K | 0.14% | 200 |
|
|
2024
Q3 | $322K | Sell |
693
-244
| -26% | -$113K | 0.17% | 180 |
|
|
2024
Q2 | $439K | Buy |
937
+387
| +70% | +$181K | 0.22% | 143 |
|
|
2024
Q1 | $230K | Buy |
+550
| New | +$230K | 0.14% | 210 |
|